Advisory Research’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-6,299
Closed -$1.01M – 370
2019
Q1
$1.01M Buy
6,299
+476
+8% +$73.8K 0.02% 241
2018
Q4
$898K Sell
5,823
-4,597
-44% -$716K 0.02% 247
2018
Q3
$1.57M Buy
10,420
+222
+2% +$31.5K 0.03% 222
2018
Q2
$1.38M Buy
10,198
+879
+9% +$109K 0.02% 243
2018
Q1
$1.24M Buy
+9,319
New +$1.25M 0.02% 255
2014
Q2
– Sell
-789
Closed -$69K – 391
2014
Q1
$69K Buy
+789
New +$69.3K ﹤0.01% 548

Other funds holding CLX

Advisory Research's CLX Position: Q2 2019 in Review

Advisory Research sold out of Clorox (CLX) in Q2 2019, closing a stake of 6,299 shares — an estimated $1.01M sold.

Advisory Research first reported a position in CLX in Q1 2014 and held it in 6 quarters. The position peaked at $1.57M in Q3 2018. 966 funds tracked by Wall St. Rank hold CLX as of Q2 2019.

  • Advisory Research reported no remaining Clorox position as of Q2 2019 after selling out during the quarter.
  • Advisory Research sold 6,299 Clorox shares in Q2 2019, an estimated $1.01M.
  • Advisory Research first reported a position in Clorox in Q1 2014 and held it in 6 quarters.
  • Advisory Research's Clorox position peaked at $1.57M in Q3 2018.
  • 966 funds tracked by Wall St. Rank held Clorox as of Q2 2019.

Based on Advisory Research's 13F filing for Q2 2019, filed 14 Aug 2019.